{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:50:46Z","timestamp":1780044646556,"version":"3.53.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Ministerio de Econom\u00eda y Competitividad (MINECO), Junta de Andaluc\u00eda and FEDER","award":["FQM-1602 and CTQ2015-68813-R"],"award-info":[{"award-number":["FQM-1602 and CTQ2015-68813-R"]}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.urology.2016.11.004","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T18:33:40Z","timestamp":1478802820000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["European Randomized Study of Screening for Prostate Cancer Risk Calculator: External Validation, Variability, and Clinical Significance"],"prefix":"10.1016","volume":"102","author":[{"given":"Enrique","family":"G\u00f3mez-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Carrasco-Valiente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Blanca-Pedregosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Barco-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Fernandez-Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Molina-Abril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Valero-Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Font-Ugalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Requena-Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2016.11.004_bib0010","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urology.2016.11.004_bib0015","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMp1510443","article-title":"Trends in metastatic breast and prostate cancer\u2014lessons in cancer dynamics","volume":"373","author":"Welch","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2016.11.004_bib0020","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1373\/clinchem.2004.046086","article-title":"Biological variation of total prostate-specific antigen: a survey of published estimates and consequences for clinical practice","volume":"51","author":"Soletormos","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.urology.2016.11.004_bib0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.urology.2016.11.004_bib0030","article-title":"Screening for prostate cancer","author":"Ilic","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.urology.2016.11.004_bib0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ucl.2015.08.003","article-title":"Urinary biomarkers for prostate cancer","volume":"43","author":"Tosoian","year":"2016","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urology.2016.11.004_bib0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ucl.2015.08.002","article-title":"New genetic markers for prostate cancer","volume":"43","author":"Leapman","year":"2016","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urology.2016.11.004_bib0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MOU.0000000000000316","article-title":"Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer","volume":"26","author":"Loeb","year":"2016","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.urology.2016.11.004_bib0050","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/annonc\/mdu525","article-title":"Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis","volume":"26","author":"Louie","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urology.2016.11.004_bib0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.eururo.2011.11.012","article-title":"Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators","volume":"61","author":"Roobol","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.11.004_bib0060","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.urology.2014.02.035","article-title":"Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer","volume":"83","author":"Ankerst","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.11.004_bib0065","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s11845-015-1291-8","article-title":"Predicting prostate cancer: analysing the clinical efficacy of prostate cancer risk calculators in a referral population","volume":"184","author":"Foley","year":"2015","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.urology.2016.11.004_bib0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bju.13314","volume":"117","author":"Poyet","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.11.004_bib0075","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urology.2016.11.004_bib0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2490-9-14","article-title":"A systematic review of the diagnostic accuracy of prostate specific antigen","volume":"9","author":"Harvey","year":"2009","journal-title":"BMC Urol"},{"key":"10.1016\/j.urology.2016.11.004_bib0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0090-4295(99)80450-6","article-title":"Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population","volume":"47","author":"Komatsu","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.11.004_bib0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000067981","article-title":"Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination","volume":"36","author":"Morote","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.11.004_bib0095","doi-asserted-by":"crossref","DOI":"10.1111\/bju.13437","article-title":"The ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of prostate cancer; a multi-institutional study","author":"Foley","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.11.004_bib0100","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1464-410X.2006.06401.x","article-title":"Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK","volume":"98","author":"Brindle","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.11.004_bib0105","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.eururo.2008.05.022","article-title":"The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review","volume":"54","author":"Schroder","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.11.004_bib0110","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw165","article-title":"Repeat prostate-specific antigen tests before prostate biopsy decisions","volume":"108","author":"Nordstrom","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2016.11.004_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2016.06.079","article-title":"Prostate MRI and MRI-targeted biopsy in patients with a prior negative biopsy: a consensus statement of the American Urological Association and the Society of Abdominal Radiology's Prostate Cancer Disease-Focused Panel","author":"Rosenkrantz","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.11.004_bib0120","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.eururo.2015.11.018","article-title":"Risk-based patient selection for magnetic resonance imaging-targeted prostate biopsy after negative transrectal ultrasound-guided random biopsy avoids unnecessary magnetic resonance imaging scans","volume":"69","author":"Alberts","year":"2016","journal-title":"Eur Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429516308081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429516308081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T15:48:29Z","timestamp":1656172109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429516308081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":23,"alternative-id":["S0090429516308081"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2016.11.004","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European Randomized Study of Screening for Prostate Cancer Risk Calculator: External Validation, Variability, and Clinical Significance","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2016.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}